These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 25617935)
1. Inhaled insulin's long journey to commercialization. Mehr SR Am J Manag Care; 2014 May; 20(8 Spec No.):E15. PubMed ID: 25617935 [No Abstract] [Full Text] [Related]
2. Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus. Kugler AJ; Fabbio KL; Pham DQ; Nadeau DA Pharmacotherapy; 2015 Mar; 35(3):298-314. PubMed ID: 25809179 [TBL] [Abstract][Full Text] [Related]
3. [A new therapeutic option for diabetes patients]. Mihălţan F; Ulmeanu R; Râşnoveanu R Pneumologia; 2005; 54(4):181-5. PubMed ID: 17069221 [TBL] [Abstract][Full Text] [Related]
4. Inhaled human insulin. Owens DR; Grimley J; Kirkpatrick P Nat Rev Drug Discov; 2006 May; 5(5):371-2. PubMed ID: 16802444 [No Abstract] [Full Text] [Related]
10. The lungs have it. Inhaled insulin therapy. Terwilliger M Adv Nurse Pract; 2007 Nov; 15(11):28-34; quiz 35. PubMed ID: 19998911 [No Abstract] [Full Text] [Related]
11. Inhaled insulin for diabetes mellitus. McMahon GT; Arky RA N Engl J Med; 2007 Feb; 356(5):497-502. PubMed ID: 17267909 [No Abstract] [Full Text] [Related]
12. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus. Mathieu C Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394 [TBL] [Abstract][Full Text] [Related]
13. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study. Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387 [TBL] [Abstract][Full Text] [Related]
14. Years in the making: inhaled insulin has finally arrived. Strain J S D Med; 2006 Jul; 59(7):301-2. PubMed ID: 16895053 [No Abstract] [Full Text] [Related]
15. Inhaled insulin is approved in Europe and United States. Lenzer J BMJ; 2006 Feb; 332(7537):321. PubMed ID: 16470037 [No Abstract] [Full Text] [Related]
16. Two cheers for inhaled insulin. Gale EA Lancet; 2001 Feb; 357(9253):324-5. PubMed ID: 11210986 [No Abstract] [Full Text] [Related]
17. Selection and education of patients for inhaled insulin. Bellary S; Barnett AH Curr Diab Rep; 2007 Oct; 7(5):363-8. PubMed ID: 18173969 [TBL] [Abstract][Full Text] [Related]
18. A breath of life for inhaled insulin: severe subcutaneous insulin resistance as an indication? Mastrandrea LD Pediatr Diabetes; 2010 Sep; 11(6):377-9. PubMed ID: 20738801 [No Abstract] [Full Text] [Related]
19. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258 [TBL] [Abstract][Full Text] [Related]
20. A patient's opinion of unmet need. Hernandez M; Mehr SR Am J Manag Care; 2014 May; 20(8 Spec No.):E16. PubMed ID: 25617936 [No Abstract] [Full Text] [Related] [Next] [New Search]